Anticoagulant polypeptide and application thereof
A technology of anticoagulation and blood coagulation, which is applied in the field of medicine and biology, and can solve unseen problems
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0038] Embodiment 1, the screening of anticoagulant polypeptide
[0039] 1. Preparation of polypeptides
[0040] Using bioinformatics analysis to find the Kunitz sequence of Schistosoma haematobium, analyze these sequences, select the Kunitz sequence with complete structure, use the Signal P3.1 server to predict its signal peptide cleavage site, and name the target sequence as shp. Using pET28a as the expression vector, a recombinant plasmid containing the target sequence was constructed.
[0041] Six Schistosoma haematobium Kunitz sequences were named shp1, shp2, shp3, shp4, shp5 and shp6. According to the conserved sequence and three-dimensional modeling of the Kunitz polypeptide, the six cysteines in the sequence form three pairs of disulfide bonds in the way of CI~CVI, CIII~CV, and CII~CIV ( figure 1 )
[0042] in,
[0043] The nucleotide sequence of shp4 is shown in SEQ ID NO.1 (the TGA at the end is a stop codon)
[0044] SEQ ID NO.1:
[0045] TTTCGCAAAGGCAGCAGCGTG...
Embodiment 2
[0058] Embodiment 2, detection of target blood coagulation factor activity
[0059] In this example, the inhibitory effect of the anticoagulant active polypeptide shp4 on coagulation factors FXIa and XIIa was detected, and the residual activity of coagulation factors after incubation with the polypeptide was detected by substrate luminescence method.
[0060] 1. Detection of coagulation factor Xia (FXIa)
[0061] (1) Dilute each recombinant polypeptide prepared in Example 1 into 10 μM, 5 μM, 2.5 μM, 1.25μM, 0.625μM, 0.3125μM, 0 total seven concentration gradients, and then use coagulation factor buffer A to mix Ⅺa (Ⅺa was purchased from Haematologic Technologies Inc, product number: HCⅪA-0160) and the corresponding substrate (substrate of Ⅺa The substance is S2366, which was purchased from Chromogenix, product number 82109039), and diluted to 1.5 μg / mL and 1200 μM, respectively.
[0062] (2) Add 50 μl Ⅺa and 50 μl peptides of different concentrations to the wells of the 96-w...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com